Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:58 PM
Ignite Modification Date:
2025-12-24 @ 7:58 PM
NCT ID:
NCT03192904
Eligibility Criteria:
Inclusion Criteria:
* 1\. Age: 18 to 70 years old; 2. Pulmonary nodules or GGO found in chest CT examination, and conform with indications for segmentectomy mentioned in NCCN guidelines:
1. Poor pulmonary reserve or other major comorbidity that contraindicates lobectomy;
2. Peripheral nodule ≤2 cm with at least one of the following:
<!-- -->
1. Pure (Adenocarcinoma in situ) AIS histology;
2. Nodule has ≥50% ground-glass appearance on CT;
3. Radiologic surveillance confirms a long doubling time (≥400 days). 3. Normal in preoperative tests, such as blood routine examination, liver function, renal function, coagulation function, etc.
4\. ASA score: Grade I-III. 5. Patients who can coordinate the treatment and research and sign the informed consent.
Exclusion Criteria:
* 1\. Patients have history of malignant tumor, or have accepted neoadjuvant chemotherapy and(or) radiotherapy.
2\. Patients have comorbidities in cardiovascular, kidney, lung or hematopoietic system, who cannot tolerate the surgery.
3\. Psychiatric patients。 4. Patient have history of chest trauma or surgery on ipsilateral chest.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT03192904
Study Brief:
Protocol Section:
NCT03192904